MIM-D3 Ophthalmic Solution

DRUG2 trials

Sponsors

Mimetogen Pharmaceuticals USA, Inc.

Conditions

Dry EyeDry Eye Syndromes

Phase 2

Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye

CompletedNCT01257607

Mimetogen Pharmaceuticals USA, Inc.Dry Eye

Start: 2010-11-30End: 2011-05-31Updated: 2019-08-19

Phase 3

A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye

CompletedNCT01960010

Mimetogen Pharmaceuticals USA, Inc.Dry Eye Syndromes

Start: 2013-10-31End: 2014-08-31Updated: 2019-08-19